356 related articles for article (PubMed ID: 14662531)
1. Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy.
Capussotti L; Massucco P; Ribero D; Viganò L; Muratore A; Calgaro M
Arch Surg; 2003 Dec; 138(12):1316-22. PubMed ID: 14662531
[TBL] [Abstract][Full Text] [Related]
2. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.
Richter A; Niedergethmann M; Sturm JW; Lorenz D; Post S; Trede M
World J Surg; 2003 Mar; 27(3):324-9. PubMed ID: 12607060
[TBL] [Abstract][Full Text] [Related]
4. Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases.
Zhou GW; Wu WD; Xiao WD; Li HW; Peng CH
Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):130-4. PubMed ID: 15730937
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma of the head of the pancreas.
Onoue S; Katoh T; Chigira H; Shibata Y; Matsuo K; Suzuki M
Hepatogastroenterology; 2002; 49(44):549-52. PubMed ID: 11995493
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer.
Pawlik TM; Abdalla EK; Barnett CC; Ahmad SA; Cleary KR; Vauthey JN; Lee JE; Evans DB; Pisters PW
Arch Surg; 2005 Jun; 140(6):584-9; discussion 589-91. PubMed ID: 15967906
[TBL] [Abstract][Full Text] [Related]
7. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.
Benassai G; Mastrorilli M; Mosella F; Mosella G
J Exp Clin Cancer Res; 1999 Mar; 18(1):23-8. PubMed ID: 10374672
[TBL] [Abstract][Full Text] [Related]
8. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head.
Leach SD; Lee JE; Charnsangavej C; Cleary KR; Lowy AM; Fenoglio CJ; Pisters PW; Evans DB
Br J Surg; 1998 May; 85(5):611-7. PubMed ID: 9635805
[TBL] [Abstract][Full Text] [Related]
9. [Patients with non-advanced pancreatic cancer benefit from extended lymphadenectomy].
Popiela T; Kedra B; Sierzega M; Kubisz A
Zentralbl Chir; 2002 Nov; 127(11):960-4. PubMed ID: 12476369
[TBL] [Abstract][Full Text] [Related]
10. Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy.
van Geenen RC; ten Kate FJ; de Wit LT; van Gulik TM; Obertop H; Gouma DJ
Surgery; 2001 Feb; 129(2):158-63. PubMed ID: 11174708
[TBL] [Abstract][Full Text] [Related]
11. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.
Wagner M; Redaelli C; Lietz M; Seiler CA; Friess H; Büchler MW
Br J Surg; 2004 May; 91(5):586-94. PubMed ID: 15122610
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic carcinoma: reappraisal of surgical experiences in one Japanese university hospital.
Yamaguchi K; Shimizu S; Yokohata K; Noshiro H; Chijiiwa K; Tanaka M
Hepatogastroenterology; 1999; 46(30):3257-62. PubMed ID: 10626197
[TBL] [Abstract][Full Text] [Related]
13. Pancreaticoduodenectomy: a 20-year experience in 516 patients.
Schmidt CM; Powell ES; Yiannoutsos CT; Howard TJ; Wiebke EA; Wiesenauer CA; Baumgardner JA; Cummings OW; Jacobson LE; Broadie TA; Canal DF; Goulet RJ; Curie EA; Cardenes H; Watkins JM; Loehrer PJ; Lillemoe KD; Madura JA
Arch Surg; 2004 Jul; 139(7):718-25; discussion 725-7. PubMed ID: 15249403
[TBL] [Abstract][Full Text] [Related]
14. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update.
van Geenen RC; van Gulik TM; Offerhaus GJ; de Wit LT; Busch OR; Obertop H; Gouma DJ
Eur J Surg Oncol; 2001 Sep; 27(6):549-57. PubMed ID: 11520088
[TBL] [Abstract][Full Text] [Related]
15. Pancreaticoduodenectomy for periampullary adenocarcinoma.
Andersen HB; Baden H; Brahe NE; Burcharth F
J Am Coll Surg; 1994 Nov; 179(5):545-52. PubMed ID: 7952456
[TBL] [Abstract][Full Text] [Related]
16. An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma.
Stojadinovic A; Brooks A; Hoos A; Jaques DP; Conlon KC; Brennan MF
J Am Coll Surg; 2003 Jun; 196(6):954-64. PubMed ID: 12788434
[TBL] [Abstract][Full Text] [Related]
17. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur.
Shahrudin MD
Int Surg; 1997; 82(3):269-74. PubMed ID: 9372373
[TBL] [Abstract][Full Text] [Related]
19. Ductal adenocarcinoma of the pancreas head: survival after regional versus extended lymphadenectomy.
Henne-Bruns D; Vogel I; Lüttges J; Klöppel G; Kremer B
Hepatogastroenterology; 1998; 45(21):855-66. PubMed ID: 9684147
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of combined pancreas and portal vein resection in surgery for pancreatic adenocarcinoma.
Aramaki M; Matsumoto T; Etoh T; Ishio T; Himeno Y; Sasaki A; Yada K; Kawano K; Kitano S
Hepatogastroenterology; 2003; 50(49):263-6. PubMed ID: 12630036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]